InsidersTradesSigma
Follow the Novacyt S.A. stock price and the full insider trade history of the company, a listed issuer based in United Kingdom. Shares trade on UK GB, under the supervision of RNS (LSE). Market capitalisation: €24.8m. The latest transaction was disclosed on 30 March 2026 (Purchase). Among the most active insiders: 1) CEO 2) Chairman 3) NED. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Novacyt S.A. is a biotechnology company focused on developing diagnostic tests for infectious diseases. It is listed on the London market under the ticker XLON.